Future considerations for pharmacologic adjuvants in single-injection peripheral nerve blocks for patients with diabetes mellitus

Regional Anesthesia and Pain Medicine

Volumn 34, Issue 5, 2009, Pages 445-457

  Williams, Brian A ^a   Murinson, Beth B ^b   Grable, Benjamin R ^a   Orebaugh, Steven L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BUPRENORPHINE; CLONIDINE; DEXAMETHASONE; DEXMEDETOMIDINE; INSULIN; INTERLEUKIN 1BETA; MIDAZOLAM; TRAMADOL; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA MECHANISM; ANESTHESIST; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG ACTIVITY; DRUG SAFETY; HISTOPATHOLOGY; HUMAN; LOCAL ANESTHESIA; NERVE BLOCK; NERVE CONDUCTION; NERVE INJURY; NERVE STIMULATION; NONHUMAN; POLYNEUROPATHY; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; REVIEW; STREPTOZOCIN DIABETES; TAXONOMY; VIGNETTE;

ADJUVANTS, PHARMACEUTIC; ANESTHETICS, LOCAL; ANIMALS; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; EXTREMITIES; HUMANS; INJECTIONS; NERVE BLOCK; PERIPHERAL NERVES; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SURGICAL PROCEDURES, ELECTIVE; TRANSLATIONAL RESEARCH;

EID: 62949212043     PISSN: 10987339     EISSN: None     Source Type: Journal    
DOI: 10.1097/AAP.0b013e3181ac9e42     Document Type: Review

References (122)

1. Martyn JAJ, Kaneki M, Yasuhara S. Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. Anesthesiology. 2008;109:137-148.
2. Bagry HS, Raghavendran S, Carli F. Metabolic syndrome and insulin resistance: perioperative considerations. Anesthesiology. 2008;108:506-523.
3. Dobretsov M, Ghaleb AH, Romanovsky D, Pablo CS, Stimers JR. Impaired insulin signaling as a potential trigger of pain in diabetes and prediabetes. Int Anesthesiol Clin. 2007;45:95-105.
4. Horowitz SH. Recent clinical advances in diabetic polyneuropathy. Curr Opin Anaesthesiol. 2006;19:573-578.
5. Williams BA, Murinson BB. Diabetes mellitus and subclinical neuropathy-a call for new paths in peripheral nerve block research. Anesthesiology. 2008;109:361-362.
6. Rigaud M, Filip P, Lirk P, Fuchs A, Gemes G, Hogan Q. Guidance of block needle insertion by electrical nerve stimulation: a pilot study of the resulting distribution of injected solution in dogs. Anesthesiology. 2008;109:473-478.
7. Pare M, Albrecht PJ, Noto CJ, Bodkin NL, Pittenger GL, Schreyer DJ, et al. Differential hypertrophy and atrophy among all types of cutaneous innervation in the glabrous skin of the monkey hand during aging and naturally occurring type 2 diabetes. J Comp Neurol. 2007;501:543-567.
8. Guberski DL. Diabetes-prone and diabetes-resistant BB rats: animal models of spontaneous and virally-induced diabetes mellitus, lymphocytic thyroiditis, and collagen-induced arthritis. ILAR J. 1993;35:29-37.
9. Brussee V, Guo G, Dong Y, Cheng C, Martinez J, Smith D, et al. Distal degenerative sensory neuropathy in a long term type 2 diabetes rat model. Diabetes. 2008;57:1664-1673.
10. H1 cells induce diabetes in NOD/SCID mice. J Clin Invest. 1998;101:68-73.
11. Price SA, Zeef LA, Wardleworth L, Hayes A, Tomlinson DR. Identification of changes in gene expression in dorsal root ganglia in diabetic neuropathy: correlation with functional deficits. J Neuropathol Exp Neurol. 2006;65:722-732.
12. Rood PP, Bottino R, Balamurugan AN, Smetanka C, Ezzelarab M, Busch J, et al. Induction of diabetes in cynomolgus monkeys with high-dose streptozotocin: adverse effects and early responses. Pancreas. 2006;33:287-292.
13. Hara H, Lin YJ, Zhu X, Tai HC, Ezzelarab M, Balamurugan AN, et al. Safe induction of diabetes by high-dose streptozotocin in pigs. Pancreas. 2008;36:31-38.
14. Kalichman MW, Calcutt NA. Local anesthetic-induced conduction block and nerve fiber injury in streptozotocin-diabetic rats. Anesthesiology. 1992;77:941-947.
15. Calcutt NA. Modeling diabetic sensory neuropathy in rats. Methods Mol Med. 2004;99:55-65
16. Kalichman MW, Powell HC, Calcutt NA, Mizisin AP. Mast cell degranulation and blood-nerve barrier permeability in rat sciatic nerve after 7 days of hyperglycemia. Am J Physiol. 1995;268:H740-H748.
17. Kalichman MW, Powell HC, Mizisin AP. Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol. 1998;95:47-56.
18. LeRoith D, Gavrilova O. Mouse models created to study the pathophysiology of type 2 diabetes. Int J Biochem Cell Biol. 2006;38:904-912.
19. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell. 2000;6:87-97.
20. Selander D. Neurotoxicity of local anesthetics: animal data. Reg Anesth. 1993;18:461-468.
21. Sinnreich M, Taylor BV, Dyck PJB. Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Neurologist. 2005;11:63-79.
22. Boulton AJM, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:956-962.
23. Kelkar P. Diabetic neuropathy. Sem Neurol. 2005;25:168-173.
24. Gooch C, Podwall D. The diabetic neuropathies. Neurologist. 2004;10:311-322.
25. Smith AG, Singleton JR. Impaired glucose tolerance and neuropathy. Neurologist. 2008;14:23-29.
26. Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Di Lembo S, et al. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care. 2007;30:83-88.
27. Tomlinson DR, Gardiner NJ. Diabetic neuropathies: components of etiology. J Peripher Nerv Syst. 2008;13:112-121.
28. Tracy JA, Dyck PJB. The spectrum of diabetic neuropathies. Phys Med Rehabil Clin N Am. 2008;19:1-26.
29. Sima AAF. Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical data. CNS Drugs. 2007;21(suppl 1):13-23; discussion 45-46.
30. Chong MS, Hester J. Diabetic painful neuropathy: current and future treatment options [published correction appears in Drugs. 2007;67:1702.
31. Drugs. 2007;67:569-585.
32. Sites BD, Gallagher J, Sparks M. Ultrasound-guided popliteal block demonstrates an atypical motor response to nerve stimulation in 2 patients with diabetes mellitus. Reg Anesth Pain Med. 2003;28:479-482.
33. Blumenthal S, Borgeat A, Maurer K, Beck-Schimmer B, Kliesch U, Marquardt M, et al. Preexisting subclinical neuropathy as a risk factor for nerve injury after continuous ropivacaine administration through a femoral nerve catheter. Anesthesiology. 2006;105:1053-1056.
34. Hebl JR, Kopp SL, Schroeder DR, Horlocker TT. Neurologic complications after neuraxial anesthesia or analgesia in patients with preexisting peripheral sensorimotor neuropathy or diabetic polyneuropathy. Anesth Analg. 2006;103:1294-1299.
35. Donatelli F, Vavassori A, Bonfanti S, Parrella P, Lorini L, Fumagalli R, et al. Epidural anesthesia and analgesia decrease the postoperative incidence of insulin resistance in preoperative insulin-resistant subjects only. Anesth Analg. 2007;104:1587-1593.
36. Neal JM. Effects of epinephrine in local anesthetics on the central and peripheral nervous systems: neurotoxicity and neural blood flow. Reg Anesth Pain Med. 2003;28:124-134.
37. Olsson Y, Save-Soderbergh J, Sourander P, Angervall L. A patho-anatomical study of the central and peripheral nervous system in diabetes of early onset and long duration. Pathol Eur. 1968;3:62-79.
38. Selvarajah D, Wilkinson ID, Emery CJ, Harris ND, Shaw PJ, Witte DR, et al. Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care. 2006;29:2664-2669.
39. McCartney CJL, Duggan E, Apatu E. Should we add clonidine to local anesthetic for peripheral nerve blockade? A qualitative systematic review of the literature. Reg Anesth Pain Med. 2007;32:330-338.
40. Eisenach JC, De Kock M, Klimscha W. Alpha (2) -adrenergic agonists for regional anesthesia. A clinical review of clonidine (1984-1995). Anesthesiology. 1996;85:655-674.
41. Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm. 2004;61:160-173.
42. Kroin JS, Buvanendran A, Beck DR, Topic JE, Watts DE, Tuman KJ. Clonidine prolongation of lidocaine analgesia after sciatic nerve block in rats Is mediated via the hyperpolarization-activated cation current, not by alpha-adrenoreceptors. Anesthesiology. 2004;101:488-494.
43. Bernard JM, Macaire P. Dose-range effects of clonidine added to lidocaine for brachial plexus block. Anesthesiology. 1997;87:277-284.
44. Iskandar H, Guillaume E, Dixmerias F, Binje B, Rakotondriamihary S, Thiebaut R, et al. The enhancement of sensory blockade by clonidine selectively added to mepivacaine after midhumeral block. Anesth Analg. 2001;93:771-775.
45. Casati A, Magistris L, Beccaria P, Cappelleri G, Aldegheri G, Fanelli G. Improving postoperative analgesia after axillary brachial plexus anesthesia with 0.75% ropivacaine. A double-blind evaluation of adding clonidine. Minerv Anestesiol. 2001;67:407-412.
46. Sia S, Lepri A. Clonidine administered as an axillary block does not affect postoperative pain when given as the sole analgesic. Anesth Analg. 1999;88:1109-1112.
47. Whiting DJ, Williams BA, Orebaugh SL, Toshok RR. Case report: postoperative analgesia and preserved motor function with clonidine and buprenorphine via a sciatic perineural catheter. J Clin Anesth. 2009. In press-June 2009.
48. Eisenach JC, Dewan DM, Rose JC, Angelo JM. Epidural clonidine produces antinociception, but not hypotension, in sheep. Anesthesiology. 1987;66:496-501.
49. Gordh T Jr, Post C, Olsson Y. Evaluation of the toxicity of subarachnoid clonidine, guanfacine, and a substance P-antagonist on rat spinal cord and nerve roots: light and electron microscopic observations after chronic intrathecal administration. Anesth Analg. 1986;65:1303-1311.
50. Lavand'homme PM, Eisenach JC. Perioperative administration of the alpha2-adrenoceptor agonist clonidine at the site of nerve injury reduces the development of mechanical hypersensitivity and modulates local cytokine expression. Pain. 2003;105:247-254.
51. Byas-Smith MG, Max MB, Muir J, Kingman A. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design. Pain. 1995;60:267-274. 51. Brummett CM, Norat MA, Palmisano JM, Lydic R. Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in rat. Anesthesiology. 2008;109:502-511.
52. Candido KD, Winnie AP, Ghaleb AH, Fattouh MW, Franco CD. Buprenorphine added to the local anesthetic for axillary brachial plexus block prolongs postoperative analgesia. Reg Anesth Pain Med. 2002;27:162-167.
53. Candido KD, Franco CD, Khan MA, Winnie AP, Raja DS. Buprenorphine added to the local anesthetic for brachial plexus block to provide postoperative analgesia in outpatients. Reg Anesth Pain Med. 2001;26:352-356.
54. Koppert W, Ihmsen H, Korber N, Wehrfritz A, Sittl R, Schmelz M, et al. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain. 2005;118:15-22.
55. Simonnet G. Opioids: from analgesia to anti-hyperalgesia? Pain. 2005;118:8-9.
56. Khan FA, Hamdani GA. Comparison of intrathecal fentanyl and buprenorphine in urological surgery [published correction appears in J Pak Med As Soc. 2006;56:482].
57. J Pak Med As Soc. 2006;56:277-281. [Note dosage error in abstract].
58. Dahm PO, Nitescu PV, Appelgren LK, Curelaru ID. Intrathecal infusion of bupivacaine with or without buprenorphine relieved intractable pain in three patients with vertebral compression fractures caused by osteoporosis. Reg Anesth Pain Med. 1999;24:352-357.
59. Lundborg C, Dahm P, Nitescu P, Appelgren L, Curelaru I. Clinical experience using intrathecal (IT) bupivacaine infusion in three patients with complex regional pain syndrome type I (CRPS-I). Acta Anaesthesiol Scand. 1999;43:667-678.
60. Lundborg CN, Nitescu PV, Appelgren LK, Curelaru ID. Progressive systemic sclerosis: intrathecal pain management. Reg Anesth Pain Med. 1999;24:89-93.
61. Dahm PO, Nitescu PV, Appelgren LK, Curelaru ID. Six years of continuous intrathecal infusion of opioid and bupivacaine in the treatment of refractory pain due to intrapelvic extrusion of bone cement after total hip arthroplasty. Reg Anesth Pain Med. 1998;23:315-319.
62. Nitescu P, Dahm P, Appelgren L, Curelaru I. Continuous infusion of opioid and bupivacaine by externalized intrathecal catheters in long-term treatment of "refractory" nonmalignant pain. Clin J Pain. 1998;14:17-28.
63. Shah FR, Halbe AR, Panchal ID, Goodchild CS. Improvement in postoperative pain relief by the addition of midazolam to an intrathecal injection of buprenorphine and bupivacaine. Eur J Anaesthesiol. 2003;20:904-910.
64. Scherer R, Schmutzler M, Giebler R, Erhard J, Stocker L, Kox WJ. Complications related to thoracic epidural analgesia: a prospective study in 1071 surgical patients. Acta Anaesthesiol Scand. 1993;37:370-374.
65. Endoh M, Matsuda A. Epidural administration of buprenorphine after combined spinal epidural anesthesia [in Japanese]. Masui (Jpn J Anesthesiol). 1996;45:1396-1399.
66. Okada K, Okada S, Nishitani K. Effect of epidural pressure gradient on buprenorphine flux through the dural hole after combined spinal-epidural anesthesia-comparison between bolus injection and continuous infusion [in Japanese]. Masui (Jpn J Anesthesiol). 1998;47:64-68.
67. Kakiuchi M, Abe K. Pre-incisional caudal epidural blockade and the relief of pain after lumbar spine operations. Int Orthop. 1997;21:62-66.
68. Hans G. Buprenorphine-a review of its role in neuropathic pain. J Opioid Manag. 2007;3:195-206.
69. Jarbo K, Batra YK, Panda NB. Brachial plexus block with midazolam and bupivacaine improves analgesia. Can J Anaesth. 2005;52:822-826.
70. Cuparencu B, Horak J, Orbai P, Horak A, Lenghel A. The effects of the intraperitoneal administration of midazolam on blood glucose level and serum lipids in streptozotocin-induced diabetes in rats. Acta Physiol Hung. 1997;85:83-88.
71. Wu Y-W, Shiau J-M, Hong C-C, Hung C-P, Lu H-F, Tseng C-C. Intrathecal midazolam combined with low-dose bupivacaine improves postoperative recovery in diabetic mellitus patients undergoing foot debridement. Acta Anaesthesiol Taiwan. 2005;43:129-134.
72. Tucker AP, Lai C, Nadeson R, Goodchild CS. Intrathecal midazolam I: a cohort study investigating safety. Anesth Analg. 2004;98:1512-1520.
73. Johansen MJ, Gradert TL, Satterfield WC, Baze WB, Hildebrand K, Trissel L, et al. Safety of continuous intrathecal midazolam infusion in the sheep model. Anesth Analg. 2004;98:1528-1535.
74. Svensson BA, Welin M, Gordh T Jr, Westman J. Chronic subarachnoid midazolam (Dormicum) in the rat. Morphologic evidence of spinal cord neurotoxicity. Reg Anesth. 1995;20:426-434.
75. Malinovsky JM, Cozian A, Lepage JY, Mussini JM, Pinaud M, Souron R. Ketamine and midazolam neurotoxicity in the rabbit. Anesthesiology. 1991;75:91-97.
76. Erdine S, Yucel A, Ozyalcin S, Ozyuvaci E, Talu GK, Ahiskali B, et al. Neurotoxicity of midazolam in the rabbit. Pain. 1999;80:419-423.
77. Bozkurt P, Tunali Y, Kaya G, Okar I. Histological changes following epidural injection of midazolam in the neonatal rabbit. Paediatr Anaesth. 1997;7:385-389.
78. Haeseler G, Foadi N, Ahrens J, Dengler R, Hecker H, Leuwer M. Tramadol, fentanyl and sufentanil but not morphine block voltage-operated sodium channels. Pain. 2006;126:234-244.
79. Tsai YC, Chang PJ, Jou IM. Direct tramadol application on sciatic nerve inhibits spinal somatosensory evoked potentials in rats. Anesth Analg. 2001;92:1547-1551.
80. Guven M, Mert T, Gunay I. Effects of tramadol on nerve action potentials in rat: comparisons with benzocaine and lidocaine. Int J Neuro Sci. 2005;115:339-349.
81. Alhashemi JA, Kaki AM. Effect of intrathecal tramadol administration on postoperative pain after transurethral resection of prostate. Br J Anaesth. 2003;91:536-540.
82. Mannion S, O'Callaghan S, Murphy DB, Shorten GD. Tramadol as adjunct to psoas compartment block with levobupivacaine 0.5%: a randomized double-blinded study. Br J Anaesth. 2005;94:352-356.
83. Kapral S, Gollmann G, Waltl B, Likar R, Sladen RN, Weinstabl C, et al. Tramadol added to mepivacaine prolongs the duration of an axillary brachial plexus blockade. Anesth Analg. 1999;88:853-856.
84. Robaux S, Blunt C, Viel E, Cuvillon P, Nouguier P, Dautel G, et al. Tramadol added to 1.5% mepivacaine for axillary brachial plexus block improves postoperative analgesia dose-dependently. Anesth Analg. 2004;98:1172-1177.
85. Antonucci S. Adjuvants in the axillary brachial plexus blockade. Comparison between clonidine, sufentanil and tramadol. [Translated from Italian] Minerva Anestesiol. 2001;67:23-27.
86. Broch O, Breucking E. Comparison of clonidine and tramadol added to prilocaine brachial plexus block - analgesia, sensory and motor block. [Translated from German] Anasthesiol Intensivmed Notfallmed Schmerz Ther. 2005;40:526-531.
87. Movafegh A, Razazian M, Hajimaohamadi F, Meysamie A. Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesth Analg. 2006;102:263-267.
88. Stan T, Goodman EJ, Bravo-Fernandez C, Holbrook CR. Adding methylprednisolone to local anesthetic increases the duration of axillary block. Reg Anesth Pain Med. 2004;29:380-381.
89. Lipman ZJ, Isaacson SA. Potentially concerning reason why adding methylprednisolone to local anesthetic may increase the duration of axillary block. Reg Anesth Pain Med. 2005;30:114; author reply 114-115.
90. Shrestha BR, Maharjan SK, Tabedar S. Supraclavicular brachial plexus block with and without dexamethasone - a comparative study. Kathmandu Univ Med J. 2003;1:158-160.
91. Zhang Y-X, Hou S-J, Wang Z-J, Meng X-B, Zhang Q, Zhang H-L, et al. Application of separating brachial plexus block combined with preoperative analgesia by patient controlled intravenous analgesia in tendon repair. [Translated from Chinese] Zhonghua Wai Ke Za Zhi [Chin J Surg]. 2004;42:1153-1156.
92. Curley J, Castillo J, Hotz J, Uezono M, Hernandez S, Lim JO, et al. Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/ polyester microspheres. Anesthesiology. 1996;84:1401-1410.
93. Drager C, Benziger D, Gao F, Berde CB. Prolonged intercostal nerve blockade in sheep using controlled-release of bupivacaine and dexamethasone from polymer microspheres. Anesthesiology. 1998;89:969-979.
94. Kohane DS, Smith SE, Louis DN, Colombo G, Ghoroghchian P, Hunfeld NG, et al. Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres. Pain. 2003;104:415-421.
95. Holte K, Werner MU, Lacouture PG, Kehlet H. Dexamethasone prolongs local analgesia after subcutaneous infiltration of bupivacaine microcapsules in human volunteers. Anesthesiology. 2002;96:1331-1335.
96. Kopacz DJ, Lacouture PG, Wu D, Nandy P, Swanton R, Landau C. The dose response and effects of dexamethasone on bupivacaine microcapsules for intercostal blockade (T9 to T11) in healthy volunteers. Anesth Analg. 2003;96:576-582.
97. Mackinnon SE, Hudson AR, Gentili F, Kline DG, Hunter D. Peripheral nerve injection injury with steroid agents. Plast Reconstr Surg. 1982;69:482-490.
98. Shishido H, Kikuchi S, Heckman H, Myers RR. Dexamethasone decreases blood flow in normal nerves and dorsal root ganglia. Spine. 2002;27:581-586.
99. Rowbotham MC. Mechanisms of neuropathic pain and their implications for the design of clinical trials. Neurology. 2005;65: S66-S73.
100. Boger RH. Renal impairment: a challenge for opioid treatment? The role of buprenorphine. Palliat Med. 2006;20 (suppl 1) : S17-S23.
101. Leonelli E, Bianchi R, Cavaletti G, Caruso D, Crippa D, Garcia-Segura LM, et al. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience. 2007;144:1293-1304.
102. Chong MS, Hester J. Diabetic painful neuropathy: current and future treatment options. Drugs. 2007;67:569-585.
103. Altunkaya H, Ozer Y, Kargi E, Babuccu O. Comparison of local anaesthetic effects of tramadol with prilocaine for minor surgical procedures. Br J Anaesth. 2003;90:320-322.
104. Johansson A, Hao J, Sjolund B. Local corticosteroid application blocks transmission in normal nociceptive C-fibres. Acta Anaesthesiol Scand. 1990;34:335-338.
105. Benzon HT, Chew TL, McCarthy RJ, Benzon HA, Walega DR. Comparison of the particle sizes of different steroids and the effect of dilution: a review of the relative neurotoxicities of the steroids. Anesthesiology. 2007;106:331-338.
106. Hodgson PS, Neal JM, Pollock JE, Liu SS. The neurotoxicity of drugs given intrathecally (spinal). Anesth Analg. 1999;88:797-809.
107. Benzon HT, Gissen AJ, Strichartz GR, Avram MJ, Covino BG. The effect of polyethylene glycol on mammalian nerve impulses. Anesth Analg. 1987;66:553-559.
108. Singhal A, Cheng C, Sun H, Zochodne DW. Near nerve local insulin prevents conduction slowing in experimental diabetes. Brain Res. 1997;763:209-214.
109. Ishii DN, Lupien SB. Insulin-like growth factors protect against diabetic neuropathy: effects on sensory nerve regeneration in rats. J Neurosci Res. 1995;40:138-144.
110. Ishii DN. Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res Brain Res Rev. 1995;20:47-67.
111. Ishii DN, Glazner GW, Pu SF. Role of insulin-like growth factors in peripheral nerve regeneration. Pharmacol Ther. 1994;62:125-144.
112. Ishii DN. Insulin and related neurotrophic factors in diabetic neuropathy. Diabet Med. 1993;10 (suppl 2) :14S-15S.
113. Yasuda H, Terada M, Maeda K, Kogawa S, Sanada M, Haneda M, et al. Diabetic neuropathy and nerve regeneration. Prog Neuro Biol. 2003;69:229-285.
114. Conti G, Scarpini E, Baron P, Livraghi S, Tiriticco M, Bianchi R, et al. Macrophage infiltration and death in the nerve during the early phases of experimental diabetic neuropathy: a process concomitant with endoneurial induction of IL-1beta and p75NTR. J Neurolog Sci. 2002;195:35-40.
115. Younger DS, Rosoklija G, Hays AP, Trojaborg W, Latov N. Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies. Muscle Nerve. 1996;19:722-727.
116. Jolivalt CG, Jiang Y, Freshwater JD, Bartoszyk GD, Calcutt NA. Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats. Diabetologia. 2006;49:2775-2785.
117. Cairns BE, Sessle BJ, Hu JW. Activation of peripheral GABAA receptors inhibits temporomandibular joint-evoked jaw muscle activity. J Neurophysiol. 1999;81:1966-1969.
118. Bhisitkul RB, Villa JE, Kocsis JD. Axonal GABA receptors are selectively present on normal and regenerated sensory fibers in rat peripheral nerve. Exp Brain Res. 1987;66:659-663.
119. Brown DA, Marsh S. Axonal GABA-receptors in mammalian peripheral nerve trunks. Brain Res. 1978;156:187-191.
120. Tamanai-Shacoori Z, Shacoori V, Jolivet-Gougeon A, Vo Van J-M, Repere M, Donnio P-Y, et al. The antibacterial activity of tramadol against bacteria associated with infectious complications after local or regional anesthesia. Anesth Analg. 2007;105:524-527.
121. Choi SB, Jang JS, Park S. Tramadol enhances hepatic insulin sensitivity via enhancing insulin signaling cascade in the cerebral cortex and hypothalamus of 90% pancreatectomized rats. Brain Res Bull. 2005;67:77-86.
122. Brunner M, Goring HD. Retrograde venous perfusion (RVP in ulcero-mutilating neuropathy) [in German]. Hautarzt. 2001;52:956-961.